Product
Follitropin Delta
Aliases
Follitropin Delta (FE 999049), REKOVELLE
4 clinical trials
2 indications
Indication
infertilityIndication
Controlled Ovarian StimulationClinical trial
A Randomised, Controlled, Assessor-blind, Parallel Groups, Multicentre Trial in India Comparing the Efficacy and Safety of FE 999049 (Follitropin Delta) With Follitropin Alfa (GONAL-F) in Controlled Ovarian Stimulation in Women Undergoing an Assisted Reproductive Technology ProgrammeStatus: Completed, Estimated PCD: 2023-12-12
Clinical trial
An Open-label Trial Investigating the Pharmacokinetics of FE 999049 Given as a Single Subcutaneous Dose in Gonadotropin Down-regulated Healthy Chinese WomenStatus: Completed, Estimated PCD: 2019-11-28
Clinical trial
A Controlled, Assessor-blind, Parallel Groups, Multicentre, Multinational Trial Evaluating the Immunogenicity of FE 999049 in Repeated Cycles of Controlled Ovarian Stimulation in Women Undergoing an Assisted Reproductive Technology ProgrammeStatus: Completed, Estimated PCD: 2015-05-01
Clinical trial
Prospective Multicentre Non-Interventional Study to Assess the Patterns of Use of REKOVELLE® in Women Undergoing In Vitro Fertilisation or Intracytoplasmic Sperm Injection Procedures in Routine Clinical PracticeStatus: Completed, Estimated PCD: 2020-04-17